Kestra Advisory Services’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.6M | Buy |
85,380
+1,160
| +1% | +$904K | 0.32% | 47 |
|
|
2025
Q1 | $69.6M | Buy |
84,220
+1,300
| +2% | +$1.07M | 0.34% | 36 |
|
|
2024
Q4 | $64M | Sell |
82,920
-3,633
| -4% | -$2.8M | 0.35% | 52 |
|
|
2024
Q3 | $76.7M | Sell |
86,553
-3,968
| -4% | -$3.52M | 0.42% | 35 |
|
|
2024
Q2 | $77.5M | Buy |
90,521
+14,841
| +20% | +$12.7M | 0.43% | 33 |
|
|
2024
Q1 | $58.9M | Buy |
75,680
+10,359
| +16% | +$8.06M | 0.39% | 36 |
|
|
2023
Q4 | $38.1M | Buy |
65,321
+6,343
| +11% | +$3.7M | 0.31% | 57 |
|
|
2023
Q3 | $31.7M | Buy |
58,978
+1,531
| +3% | +$822K | 0.31% | 58 |
|
|
2023
Q2 | $26.9M | Buy |
57,447
+342
| +0.6% | +$160K | 0.27% | 73 |
|
|
2023
Q1 | $19.6M | Sell |
57,105
-16,527
| -22% | -$5.68M | 0.21% | 106 |
|
|
2022
Q4 | $26.9M | Buy |
73,632
+7,786
| +12% | +$2.85M | 0.24% | 92 |
|
|
2022
Q3 | $21.3M | Sell |
65,846
-10,150
| -13% | -$3.28M | 0.23% | 97 |
|
|
2022
Q2 | $24.6M | Buy |
75,996
+24,058
| +46% | +$7.8M | 0.25% | 85 |
|
|
2022
Q1 | $14.9M | Buy |
51,938
+3,883
| +8% | +$1.11M | 0.15% | 146 |
|
|
2021
Q4 | $13.3M | Buy |
48,055
+2,917
| +6% | +$806K | 0.13% | 174 |
|
|
2021
Q3 | $10.4M | Sell |
45,138
-1,428
| -3% | -$330K | 0.1% | 213 |
|
|
2021
Q2 | $10.7M | Buy |
46,566
+1,493
| +3% | +$343K | 0.12% | 191 |
|
|
2021
Q1 | $8.42M | Sell |
45,073
-17,525
| -28% | -$3.27M | 0.11% | 222 |
|
|
2020
Q4 | $10.5M | Buy |
62,598
+18,467
| +42% | +$3.08M | 0.12% | 196 |
|
|
2020
Q3 | $6.53M | Buy |
+44,131
| New | +$6.53M | 0.12% | 202 |
|